Visiongain Launches Report Examining the Potential in the $38bn Respiratory Inhalers Market

Top 20 Global Respiratory Inhalers Manufacturers 2019

GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Roche, Novartis, Merck, Teva, Other Companies

News provided by

May 30, 2019, 05:00 ET

LONDON, May 30, 2019 /PRNewswire/ -- The global respiratory inhalers market is estimated to reach $38bn in 2023. In the respiratory Inhalers market the top three companies by revenue are GlaxoSmithKline, Boehringer Ingelheim and AstraZeneca, with 57.1% of the world market in 2018.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 144-page report you will receive 77 charts– all unavailable elsewhere.

The 144-page report provides clear detailed insight into the top 20 global respiratory inhalers manufacturers. Discover the key drivers and challenges affecting the market.

By ordering and reading Visiongain's brand-new report today you stay better informed and ready to act.

To request sample pages from this report please contact Sara Peerun at [email protected] or refer to our website: https://www.visiongain.com/report/top-20-global-respiratory-inhalers-manufacturers-2019/#download_sampe_div

Report Scope

• Global Top 20 Respiratory Inhalers Market forecasts to 2028

• Profiles of the 20 leading respiratory inhalers manufacturers:
• Aerocrine
• AMIKO Digital Health
• AstraZeneca
• BEXIMCO Pharmaceuticals
• Boehringer Ingelheim
• Chiesi Farmaceutici S.p.A.
• CIPLA
• FLUIDDA
• GlaxoSmithKline
• H&T Presspart
• Merck
• Mundipharma
• Novartis
• Omron Healthcare
• PARI Medical Holding
• PNEUMA Respiratory
• PULMATRIX
• Roche
• Sunovion Pharmaceuticals
• Teva

• The content of each profile differs, depending on the organization. In general, a profile gives the following information:
• An overview and analysis of the company
• A portfolio of the company's marketed product and product pipeline
• Financial Information
• Revenue forecast to 2028
• Recent developments
• Future Outlook

• Analysis of the drivers and restraints of the global respiratory inhalers market

• Coverage of respiratory inhalers in the R&D pipeline. Discussions of research and development – see progress in this industry, finding technological, clinical and commercial outlooks and opportunities

• Key questions Answered by This Report:
• How is the Respiratory Inhalers Manufacturers market evolving?
• What is driving and restraining the Respiratory Inhalers Manufacturers market?
• What will be the main driver for the overall market to 2028?
• Will leading Respiratory Inhalers Manufacturers broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• Who are the leading players and what are their prospects over the forecast period?

To request a report overview of this report please contact Sara Peerun at [email protected] or refer to our website: https://www.visiongain.com/report/top-20-global-respiratory-inhalers-manufacturers-2019/

Did you know that we also offer a report add-on service? Email [email protected] to discuss any customized research needs you may have.

Companies covered in the report include:

3A Health Care s.r.l.
3M Pharmaceuticals
Aerocrine (Circassia)
Aerocrine AB
Amgen
Amiko Digital Health
AstraZeneca
Beximco Pharmaceuticals Limited (Beximco Pharma)
BioCare Manufacturing Malaysia
Boehringer Ingelheim
Chiesi Farmaceutici
Ciba-Geigy
Cipla Ltd.
Circassia Pharmaceuticals
Cree
Dainippon Sumitomo Pharma America, Inc.
Dermira Inc.
EasibreatheTM
Fluidda
Genentech
General Electric
GlaxoSmithKline
Glenmark
H&T Presspart
Heitkamp & Thumann KG
Heitkamp and Thumann Group
Hovione Technology
Innoviva, Inc.
Meda
Merck
MundiPharma
Novartis
OMRON Healthcare Europe B.V.
OMRON Healthcare Group
Pari Medical Holding
PARI Pharma GmbH
Perrigo
Pfizer
Philips
Pneuma Respiratory, Inc.
Presspart Manufacturing Limited
Pulmatrix, Inc.
Roche
Sandoz
Sepracor Inc.
Sorrento
Sumitomo Dainippon Pharma Co., Ltd.
Sunovion Pharmaceuticals Inc.
Teva
Vectura
Vizient, Inc.

List of Organizations Mentioned in the Report
European Commission
European Medicines Agency (EMA)
European Respiratory Society (ERS)
Food and Drug Administration (FDA)
Japanese Ministry of Health
National Institute for Health and Care Excellence (NICE
United States Patent and Trademark Office (USPTO)
University of Maryland